Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

27. März 2002 04:28 ET | Quelle: Akzo Nobel

Akzo Nobel: Arixtra (fondaparinux sodium) Receives Marketing Authorization in the European Union

ARNHEM/OSS, The Netherlands, March 27, 2002 (PRIMEZONE) -- Akzo Nobel's (Nasdaq:AKZOY) business unit, Organon and Sanofi-Synthelabo, today announced that Arixtra(r) (fondaparinux sodium) has received...
27. März 2002 03:40 ET | Quelle: Karo Bio

Karo Bio: Update in Program to Develop Treatment for Obesity

HUDDINGE, Sweden, March 27, 2002 (PRIMEZONE) -- Karo Bio today announced that Bristol-Myers Squibb Company has discontinued development of the first thyroid hormone receptor modulator for treatment...
27. März 2002 03:16 ET | Quelle: CeNeS Pharmaceuticals Plc

CeNeS Announces Preliminary Results for the Year- Ended December 31, 2001 (with link)

CAMBRIDGE, U.K., March 27, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced its results for the year ended Dec. 31, 2001 and an update on its restructuring plan. Key events...
26. März 2002 08:50 ET | Quelle: Gyros

Gyros AB Announces First Commercial Application -- Gyrolab MALDI

UPPSALA, Sweden, March 26, 2002 (PRIMEZONE) -- Gyros AB today announced the introduction of Gyrolab(tm) MALDI SP1 and Gyrolab Workstation, the company's first products based on its proprietary...
26. März 2002 07:56 ET | Quelle: BioXell SpA

BioXell: New Immunology Company Launched; Roche Spin-Out Raises Euro 22 Million from International Investors

MILAN, Italy, March 26, 2002 (PRIMEZONE) -- BioXell SpA announced its official launch today at a press conference in Milan. The firm combines extensive industry experience with a competitive edge in...
25. März 2002 02:31 ET | Quelle: Astex Therapeutics

Astex Announces Structure-Based Drug Discovery Collaboration with Aventis Pharmaceuticals

CAMBRIDGE, U.K., March 25, 2002 (PRIMEZONE) -- Astex Technology, the private, structure-based drug discovery company, today announced a structural biology research agreement with Aventis...
25. März 2002 02:15 ET | Quelle: Astex Therapeutics

Astex Receives Milestone Payment from AstraZeneca for Human Cytochrome P450 Program

CAMBRIDGE, U.K., March 25, 2002 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, announced today that it has received the first milestone payment from AstraZeneca AB, as...
20. März 2002 11:25 ET | Quelle: Pharmexa A/S

Pharmexa Presents at the 3rd European Breast Cancer Conference in Barcelona

BARCELONA, Spain, March 20, 2002 (PRIMEZONE) -- Dr. Dana Leach, Vice President of Preclinical Development and Immunopharmacology at Pharmexa, today presented the company's HER-2 DNA AutoVac(tm)...
18. März 2002 06:29 ET | Quelle: Biacore

Biacore and Bruker Daltonics Announce First Results from Joint Studies; SPR-MS Collaboration Achieves Significant Milestones

UPPSALA, Sweden and BILLERICA, Mass., March 18, 2002 (PRIMEZONE) -- Biacore International AB (SSE:BCOR) (Nasdaq:BCOR) and Bruker Daltonics Inc. (Nasdaq:BDAL) today announced that their recent...
15. März 2002 04:30 ET | Quelle: Q-Med

Ixion Biotechnology Awarded Research Grant Within the Diabetes Area

UPPSALA, Sweden, March 15, 2002 (PRIMEZONE) -- Q-Med's majority owned subsidiary Ixion Biotechnology, Inc. in Florida has been awarded a research grant of USD 99,000 for continued studies within the...

Vorherige Seite